Does anaesthetic management affect early outcomes after lung transplant? An exploratory analysis

British Journal of Anaesthesia

Volumn 102, Issue 4, 2009, Pages 506-514

  McIlroy, D R ^a,b   Pilcher, D V ^a   Snell, G I ^a  

^a ALFRED HOSPITAL   (Australia)

^b Department of Orthopaedic Surgery   (United States)

Author keywords

Lung, gas exchange, respiratory; Lung, transplantation

Indexed keywords

FENTANYL; GELATIN SUCCINATE; MIDAZOLAM; PROPOFOL; ROPIVACAINE;

ADULT; AGED; ANESTHESIA; ARTICLE; COLLOID; CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; CONTINUOUS INFUSION; CORRELATION ANALYSIS; DRUG DOSE TITRATION; ENDOTRACHEAL INTUBATION; EXTUBATION; FEMALE; GAS EXCHANGE; GRAFT SURVIVAL; HAZARD RATIO; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LOADING DRUG DOSE; LUNG DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME VARIABLE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

EID: 62549138213     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep008     Document Type: Article

References (36)

1. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report - 2006. J Heart Lung Transplant 2006; 25: 880-92
2. Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232-41
3. Meyers BF, de la Morena M, Sweet SC, et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 2005; 129: 1421-9
4. Prekker ME, Nath DS, Walker AR, et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006; 25: 371-8
5. Whitson BA, Nath DS, Johnson AC, et al. Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg 2006; 131: 73-80
6. Christie JD, Carby M, Bag R, et al. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454-9
7. Christie JD, Van Raemdonck D, de Perrot M, et al. Report of the ISHLTworking group on primary lung graft dysfunction part I: introduction and methods. J Heart Lung Transplant 2005; 24: 1451-3
8. Christie JD, Kotloff RM, Ahya VN, et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171: 1312-6
9. Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002; 73: 1041-7
10. King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681-5
11. Thabut G, Vinatier I, Stern J-B, et al. Primary graft failure following lung transplantation: predictive factors of mortality. Chest 2002; 121: 1876-82
12. de Perrot M, Bonser RS, Dark J, et al. Report of the ISHLT working group on primary lung graft dysfunction part III: donor-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1460-7
13. Pilcher DV, Scheinkestel CD, Snell GI, et al. High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation. J Thorac Cardiovasc Surg 2005; 129: 912-8
14. Pilcher DV, Snell GI, Scheinkestel CD, et al. High donor age, low donor oxygenation, and high recipient inotrope requirements predict early graft dysfunction in lung transplant recipients. J Heart Lung Transplant 2005; 24: 1814-20
15. Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003; 124: 1232-41
16. Barr ML, Kawut SM, Whelan TP, et al. Report of the ISHLT working group on primary lung graft dysfunction part IV: recipient-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1468-82
17. Currey JA, Pilcher DV, Davies A, et al. A prospective study of a management algorithm to minimise lung transplant (LTx) primary graft dysfunction (PGD). J Heart Lung Transplant 2007; 26: S66-7
18. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999; 160: 265-71
19. Oto T, Griffiths AP, Levvey B, et al. A donor history of smoking affects early but not late outcome in lung transplantation. Transplantation 2004; 78: 599-606
20. de Perrot M, Keshavjee S. Lung preservation. Semin Thorac Cardiovasc Surg 2004; 16: 300-8
21. Oto T, Rabinov M, Griffiths AP, et al. Unexpected donor pulmonary embolism affects early outcomes after lung transplantation: a major mechanism of primary graft failure? J Thorac Cardiovasc Surg 2005; 130: 1146-52
22. McIlroy DR, Cairo SA, Buckland MR. Pulmonary vein thrombosis, lung transplantation, and intraoperative transesophageal echocardiography. J Cardiothorac Vasc Anesth 2006; 20: 712-5
23. Bittner HB, Richter M, Kuntze T, et al. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation. Eur J Cardiothorac Surg 2006; 29: 210-5
24. Meade MO, Granton JT, Matte-Martyn A, et al. A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation. Am J Respir Crit Care Med 2003; 167: 1483-9
25. Nath DS, Walter AR, Johnson AC, et al. Does Perfadex affect outcomes in clinical lung transplantation? J Heart Lung Transplant 2005; 24: 2243-8
26. Oto T, Griffiths AP, Rosenfeldt F, et al. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg 2006; 82: 1842-8
27. Oto T, Levvey B, Pilcher DV, et al. Evaluation of the oxygenation ratio in the definition of early graft dysfunction post lung transplantation. J Thorac Cardiovasc Surg 2005; 130: 180-6
28. Clark SC. Lung injury after cardiopulmonary bypass. Perfusion 2006; 21: 225-8
29. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490-511
30. Fisher AJ, Wardle J, Dark JH, Corris PA. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 2002; 21: 1206-12
31. Abraham D, Taghavi S, Riml P, et al. VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation 2002; 73: 1703-6
32. Schmid RA, Zollinger A, Singer T, et al. Effect of soluble complement receptor type I on reperfusion edema and neutrophil migration after lung allotransplantation in swine. J Thorac Cardiovasc Surg 1998; 116: 90-7
33. Shargall Y, Guenther G, Ahya VN, et al. Report of the ISHLT working group on primary lung graft dysfunction part VI: treatment. J Heart Lung Transplant 2005; 24: 1489-500
34. Vollmar B, Menger MD. Volume replacement and microhemodynamic changes in polytrauma. Langenbecks Arch Surg 2004; 389: 485-91
35. Arif SK, Verheij J, Groeneveld AB, Raijmakers PG. Hypoproteinemia as a marker of acute respiratory distress syndrome in critically ill patients with pulmonary edema. Intensive Care Med 2002; 28: 310-7
36. Groeneveld AB. Radionuclide assessment of pulmonary microvascular permeability. Eur J Nucl Med 1997; 24: 449-61